- Forums
- ASX - By Stock
- Ann: TLX101 for Glioblastoma Therapy - Clinical Trial Update
This comment has aged well
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.05 |
Change
-0.190(1.25%) |
Mkt cap ! $4.973B |
Open | High | Low | Value | Volume |
$15.25 | $15.46 | $15.01 | $19.15M | 1.257M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3385 | $15.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.16 | 8704 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3385 | 15.010 |
6 | 6009 | 15.000 |
1 | 8651 | 14.990 |
1 | 1879 | 14.980 |
3 | 3192 | 14.970 |
Price($) | Vol. | No. |
---|---|---|
15.160 | 8704 | 2 |
15.170 | 5300 | 2 |
15.180 | 1693 | 1 |
15.190 | 3421 | 1 |
15.200 | 1000 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$15.02 |
  |
Change
-0.190 ( 1.12 %) |
|||
Open | High | Low | Volume | ||
$15.33 | $15.46 | $15.02 | 192620 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
TLX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online